Table 2.
Characteristic | Level | Number of deaths, n (%) | Adjusted odds ratio (95% CI) | P value |
---|---|---|---|---|
Age | 40–49 | 10 (0.8) | reference | – |
0–39 | 5 (0.4) | 0.60 (0.20,1.77) | 0.36 | |
50–59 | 60 (4.9) | 3.62 (1.83,7.17) | < 0.001 | |
60–69 | 176 (14.4) | 8.98 (4.68,17.24) | < 0.001 | |
70–79 | 370 (30.2) | 14.53 (7.62,27.69) | < 0.001 | |
≥ 80 | 604 (49.3) | 23.77 (12.48,45.27) | < 0.001 | |
Sex | Male | 711 (58.0) | 1.41 (1.22,1.62) | < 0.001 |
Congestive heart failure | Yes | 130 (10.6) | 1.69 (1.32,2.15) | < 0.001 |
Cardiac arrhythmias | Yes | 195 (16.0) | 0.92 (0.76,1.11) | 0.38 |
COPD | Yes | 267 (21.8) | 1.43 (1.18,1.72) | < 0.001 |
Diabetes | Yes | 218 (17.8) | 1.13 (0.95,1.36) | 0.17 |
Hypertension | Yes | 298 (24.3) | 0.94 (0.80,1.10) | 0.43 |
Hypothyroidism | Yes | 37 (3.0) | 0.91 (0.62,1.34) | 0.65 |
Renal disease | Yes | 240 (19.6) | 1.81 (1.51,2.19) | < 0.001 |
Liver disease | Yes | 27 (2.2) | 2.50 (1.53,4.07) | < 0.001 |
Lymphoma | Yes | 27 (2.2) | 2.78 (1.64,4.74) | < 0.001 |
Metastatic cancer | Yes | 33 (2.7) | 2.17 (1.25,3.77) | 0.006 |
Solid tumour without metastasis | Yes | 70 (5.7) | 1.67 (1.16,2.41) | 0.006 |
Rheumatoid arthritis/ collagen vascular diseases | Yes | 22 (1.8) | 1.08 (0.66,1.79) | 0.78 |
Obesity | Yes | 21 (1.7) | 5.28 (2.92,9.52) | < 0.001 |
Asthma | Yes | 52 (4.2) | 0.60 (0.42,0.86) | 0.005 |
Depression | Yes | 20 (1.6) | 0.62 (0.37,1.00) | 0.05 |
Dementia | Yes | 187 (15.3) | 1.44 (1.17,1.76) | < 0.001 |
Neurological disorders | Yes | 72 (5.9) | 1.20 (0.90,1.61) | 0.21 |
Statistically significant P < 0.05 values are in bold.
Observations, n = 6036, including 1225 COVID-19 deaths.
CI Confidence Interval; COPD Chronic obstructive pulmonary disease.